136 related articles for article (PubMed ID: 10972897)
1. Structure-function effects in primary immunodeficiencies.
Korpi M; Väliaho J; Vihinen M
Scand J Immunol; 2000 Sep; 52(3):226-32. PubMed ID: 10972897
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients.
Dusi S; Nadalini KA; Donini M; Zentilin L; Wientjes FB; Roos D; Giacca M; Rossi F
J Immunol; 1998 Nov; 161(9):4968-74. PubMed ID: 9794433
[TBL] [Abstract][Full Text] [Related]
3. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
[TBL] [Abstract][Full Text] [Related]
4. Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis.
Porter CD; Kuribayashi F; Parkar MH; Roos D; Kinnon C
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):571-5. PubMed ID: 8615831
[TBL] [Abstract][Full Text] [Related]
5. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis of chronic granulomatous disease.
Meischl C; Roos D
Springer Semin Immunopathol; 1998; 19(4):417-34. PubMed ID: 9618766
[TBL] [Abstract][Full Text] [Related]
7. Bruton's tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling.
Qin S; Chock PB
Biochemistry; 2001 Jul; 40(27):8085-91. PubMed ID: 11434777
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical background of chronic granulomatous disease.
Jurkowska M; Bernatowska E; Bal J
Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease.
Roos D; de Boer M; Kuribayashi F; Meischl C; Weening RS; Segal AW; Ahlin A; Nemet K; Hossle JP; Bernatowska-Matuszkiewicz E; Middleton-Price H
Blood; 1996 Mar; 87(5):1663-81. PubMed ID: 8634410
[No Abstract] [Full Text] [Related]
10. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
11. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of p67phox, p47phox or gp91phox in chronic granulomatous disease does not impair leucocyte chemotaxis or motility.
Zicha D; Dunn GA; Segal AW
Br J Haematol; 1997 Mar; 96(3):543-50. PubMed ID: 9054662
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
14. [Chronic granulomatous disease].
Iwata M; Nunoi H
Ryoikibetsu Shokogun Shirizu; 2000; (32):179-82. PubMed ID: 11212682
[No Abstract] [Full Text] [Related]
15. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
16. The p47phox mouse knock-out model of chronic granulomatous disease.
Jackson SH; Gallin JI; Holland SM
J Exp Med; 1995 Sep; 182(3):751-8. PubMed ID: 7650482
[TBL] [Abstract][Full Text] [Related]
17. Cloning and sequencing of the bovine flavocytochrome b subunit proteins, gp91-phox and p22-phox: comparison with other known flavocytochrome b sequences.
Davis AR; Mascolo PL; Bunger PL; Sipes KM; Quinn MT
J Leukoc Biol; 1998 Jul; 64(1):114-23. PubMed ID: 9665285
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnosis of primary immunodeficiencies].
García Rodríguez MC; López Granados E; Cambronero Martínez R; Ferreira Cerdán A; Fontán Casariego G
Allergol Immunopathol (Madr); 2001; 29(3):107-13. PubMed ID: 11434883
[TBL] [Abstract][Full Text] [Related]
19. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Belohradsky BH; Haire RN; Holinski-Feder E; Kwan SP; Lappalainen I; Lehväslaiho H; Lester T; Meindl A; Ochs HD; Ollila J; Vorechovsky I; Weiss M; Smith CI
Nucleic Acids Res; 1997 Jan; 25(1):166-71. PubMed ID: 9016530
[TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
